Anika Therapeutics, Inc. Liquidation Value
ANIK
Other
Cash & Equivalents
$57.48M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $57.48M
Total Obligations: -$48.16M
$9.32M
Per share: $0.67
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $57.48M
AR: $23.69M
Total Obligations: -$48.16M
$33.02M
Per share: $2.38
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $57.48M
AR: $23.69M
Inventory: $18.79M
Total Obligations: -$48.16M
$51.80M
Per share: $3.73
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $9.32M | $0.67 |
| Liquid Liquidation Value | $33.02M | $2.38 |
| Operating Liquidation Value | $51.80M | $3.73 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $57.48M |
| Accounts Receivable | $23.69M |
| Inventory | $18.79M |
| Current Liabilities | $21.91M |
| Long-term Debt | N/A |
| Op. Lease Liability | $26.25M |
| Finance Lease | N/A |
| Shares Outstanding | 13.9M |
Explore all 219 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $57.48M | $23.69M | $18.79M | $6.04M | $21.91M | N/A | $26.25M | N/A |
| 2025-09-30 | $57.99M | $22.19M | $16.28M | $4.73M | $19.09M | N/A | $24.51M | N/A |
| 2025-06-30 | $53.17M | $23.95M | $16.92M | $4.77M | $16.08M | N/A | $24.99M | N/A |
▼ Community Notes